Today's Low
₹ 669.55
Today's High
₹ 680.10
52 Weeks Low
₹ 295.00
52 Weeks High
₹ 528.00
Lower
₹ 553.15
Upper
₹ 829.65
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. It offers laboratory services, including clinical biochemistry, haematology and immune-haematology, clinical pathology, histopathology and cytopathology, microbiology, serology, cytogenetics, and molecular pathology; radiology and imaging services comprising magnetic resonance imaging, multi slice CT, CBCT (3D dental), mammography, DEXA/bone densitometry, ultrasound/color doppler, nuclear medicine and PET/CT, and digital X-ray; and cardiology, neurology, and gastroenterology services. The company also provides health checkups and home sample collection services. It has a network, which consists of 80 diagnostic center and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh, and in the National Capital Region and Kolkata. The company was founded in 1981 and is based in Hyderabad, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Total Current Assets | 275.7 | 269.9 | 239.1 | 186.4 | 137.5 |
Total Non-Current Assets | 569.5 | 434.7 | 296.1 | 294.3 | 267.8 |
Total Assets | 845.2 | 704.6 | 535.1 | 480.7 | 405.3 |
Total Current Liabilities | 66.2 | 66.1 | 44.3 | 58.6 | 57.1 |
Total Non-Current Liabilities | 232.4 | 168.9 | 131.6 | 147.9 | 141.1 |
Shareholder's Funds | 544.7 | 468.2 | 359.0 | 274.5 | 207.4 |
Total Liabilities | 845.2 | 704.6 | 535.1 | 480.7 | 405.3 |
The Industry Price to BV stands at 9.81, vs the Price to BV of 11.03, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.51, vs the Quick Ratio of 3.13, which results in a Positive aspect.
The Industry Debt to Equity Ratio stands at 0.37, vs the Debt to Equity Ratio of 0.12, which results in a Positive aspect.
The Industry Current Ratio stands at 1.64, vs the Current Ratio of 3.18, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Total Income | 459.2 | 462.4 | 376.8 | 338.8 | 292.6 |
Total Expenditure | 277.2 | 258.7 | 210.8 | 206.2 | 184.5 |
Operating Profit(Excl OI) | 196.2 | 216.5 | 177.8 | 148.0 | 118.5 |
Add: Other Income | 14.2 | 12.8 | 11.9 | 15.4 | 10.4 |
Operating Profit | 196.2 | 216.5 | 177.8 | 148.0 | 118.5 |
Less: Interest | 21.0 | 16.5 | 15.3 | 15.4 | 13.5 |
PBDT | 175.2 | 200.1 | 162.6 | 132.6 | 104.9 |
Less: Depreciation Amortization | 61.7 | 52.7 | 50.5 | 49.2 | 39.6 |
PBT & Exceptional Items | 113.5 | 147.4 | 112.1 | 83.4 | 65.3 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 113.5 | 147.4 | 112.1 | 83.4 | 65.3 |
Less: Taxation | 28.3 | 36.7 | 27.0 | 20.9 | 19.1 |
Profit After Tax | 85.2 | 110.7 | 85.1 | 62.5 | 46.3 |
Earnings Per Share | 0.1 | 0.1 | 0.1 | 0.6 | 0.5 |
The Industry PAT Growth stands at 529.05, vs the PAT Growth of 35.09, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.21, vs the Dividend Yield of 0.15, which results in a Negative aspect.
The Industry PAT Margin stands at 7.78, vs the PAT Margin of 18.45, which results in a Positive aspect.
The Industry PE Ratio stands at 76.81, vs the PE Ratio of 60.95, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Profit Before Tax | 113.5 | 147.4 | 112.1 | 83.4 | 65.3 |
Tax Paid | -26.2 | -39.9 | -31.2 | -23.3 | -18.7 |
Adjustment | 68.3 | 57.2 | 53.3 | 49.2 | 43.1 |
Changes In Working Capital | 113.5 | 147.4 | 112.1 | 83.4 | 65.3 |
Cash Flow after changes in Working Capital | 190.8 | 197.9 | 160.9 | 129.4 | 109.2 |
Cash Flow from Operating Activities | 164.6 | 158.0 | 129.6 | 106.1 | 90.5 |
Cash Flow from Investing Activities | -109.6 | -123.1 | -129.7 | -30.6 | -89.8 |
Cash Flow from Financing Activities | -41.9 | -30.6 | -48.8 | -29.5 | -7.2 |
Net Cash Inflow / Outflow | 13.1 | 4.4 | -48.9 | 45.9 | -6.5 |
Opening Cash & Cash Equivalents | 11.0 | 6.7 | 55.6 | 9.6 | 16.1 |
Closing Cash & Cash Equivalent | 24.2 | 11.0 | 6.7 | 55.6 | 9.6 |
The Industry PCF RATIO stands at 31.08, vs the PCF RATIO of 0.00, which results in a Negative aspect.
The Industry PFCF Ratio stands at 95.17, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1,326.9 | 1,388.6 | 1,210.5 | 1,209.9 | 1,131.2 | 1,207.5 | 1,043.6 | 1,162.0 | 1,107.8 | 1,127.1 |
Total Income | 1,378.0 | 1,456.1 | 1,267.6 | 1,255.1 | 1,166.8 | 1,240.5 | 1,071.3 | 1,193.9 | 1,139.8 | 1,158.6 |
Total Expenditure | 803.9 | 814.9 | 729.3 | 718.9 | 688.3 | 720.1 | 644.7 | 683.4 | 629.5 | 615.6 |
PBIDT (Excl OI) | 523.1 | 573.7 | 481.2 | 491.1 | 442.9 | 487.4 | 398.9 | 478.6 | 478.3 | 511.5 |
Other Income | 51.1 | 67.5 | 57.1 | 45.2 | 35.6 | 33.0 | 27.7 | 31.9 | 32.0 | 31.6 |
Operating Profit | 574.2 | 641.2 | 538.3 | 536.3 | 478.5 | 520.5 | 426.6 | 510.5 | 510.3 | 543.0 |
Interest | 60.6 | 58.5 | 58.8 | 57.7 | 55.4 | 48.7 | 47.7 | 43.4 | 41.8 | 39.4 |
Exceptional Items | -20.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 493.1 | 582.6 | 479.4 | 478.6 | 423.1 | 471.7 | 379.0 | 467.1 | 468.5 | 503.7 |
Depreciation | 145.4 | 136.9 | 124.7 | 113.6 | 202.9 | 159.0 | 141.8 | 152.8 | 130.1 | 124.8 |
Profit Before Tax | 347.6 | 445.8 | 354.7 | 365.0 | 220.2 | 312.7 | 237.2 | 314.3 | 338.5 | 378.9 |
Tax | 87.6 | 110.0 | 90.9 | 87.7 | 55.6 | 78.0 | 61.7 | 75.5 | 83.9 | 98.9 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 260.0 | 335.7 | 263.8 | 277.3 | 164.6 | 234.7 | 175.6 | 238.8 | 254.6 | 280.0 |
Net Profit | 260.0 | 335.7 | 263.8 | 277.3 | 164.6 | 234.7 | 175.6 | 238.8 | 254.6 | 280.0 |
ADDITIONAL INFOS: | ||||||||||
Equity Capital | 102.3 | 102.3 | 102.1 | 102.1 | 102.1 | 102.1 | 102.0 | 102.0 | 102.0 | 102.0 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 2.5 | 3.3 | 2.6 | 2.7 | 1.6 | 2.3 | 1.7 | 2.3 | 2.5 | 2.7 |
Operating Profit Margin | 43.3 | 46.2 | 44.5 | 44.3 | 42.3 | 43.1 | 40.9 | 43.9 | 46.1 | 48.2 |
Net Profit Margin | 19.6 | 24.2 | 21.8 | 22.9 | 14.5 | 19.4 | 16.8 | 20.6 | 23.0 | 24.8 |
The Industry Net Sales Growth stands at 21.01, vs the Net Sales Growth of 15.80, which results in a Negative aspect.
The Industry Mcap Growth stands at 26.53, vs the Mcap Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 704.95 | 722.09 | 681.68 |
R3 | 697.65 | 696.93 | 677.26 |
R2 | 690.35 | 689.99 | 675.79 |
R1 | 681.60 | 680.88 | 674.32 |
Pivot | 674.30 | 673.94 | 674.30 |
S1 | 665.55 | 664.83 | 671.38 |
S2 | 658.25 | 657.89 | 669.91 |
S3 | 649.50 | 648.78 | 668.44 |
S4 | 640.75 | 625.79 | 664.02 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
36.53
Neutral
RSI
56.04
Neutral
ROC
2.17
Bullish
UltimateOscillator
58.46
Neutral
Williams Indicator
-41.29
Neutral
CCI Indicator
70.65
Neutral
MACD
-2,436.97
Bearish
Stochastic Indicator
63.62
Neutral
ATR
22.88
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
13-09-2023 | 1.00 | 100 | Final |
20-09-2022 | 1.00 | 100 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
05-02-2024 | Quarterly Results |
07-11-2023 | Quarterly Results |
09-08-2023 | Quarterly Results |
29-05-2023 | Dividend & Audited Results |
13-02-2023 | Quarterly Results |
10-11-2022 | Quarterly Results |
09-08-2022 | Quarterly Results |
26-05-2022 | Final Dividend & Audited Results |
04-02-2022 | Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve Unaudited standalone and consolidated financial results of the Company for the quarter ended December 31, 2021 |
08-11-2021 | Quarterly Results |